Table 3.
Variable | Reference | Characteristic | Cancer‐specific survival | ||
---|---|---|---|---|---|
HR (95%CI) | SE | P value | |||
CRM | ≤0.4 mm | 0.5‐1.0 mm | 0.834 (0.645‐1.078) | 0.131 | 0.166 |
1.1‐2.0 mm | 0.704 (0.536‐0.924) | 0.139 | 0.012 | ||
2.1‐5.0 mm | 0.773 (0.602‐0.992) | 0.127 | 0.043 | ||
5.1‐10.0 mm | 0.543 (0.397‐0.741) | 0.159 | <0.001 | ||
>10.0 mm | 0.577 (0.448‐0.742) | 0.129 | <0.001 | ||
AJCC stage | Stage I | Stage II | 2.041 (1.388‐3.001) | 0.197 | <0.001 |
Stage III | 4.361 (3.060‐6.216) | 0.181 | <0.001 | ||
Stage IV | 15.773 (10.949‐22.722) | 0.186 | <0.001 | ||
Tumor size | Unknown | ≤5 cm | 0.941 (0.685‐1.292) | 0.162 | 0.707 |
>5 cm | 1.283 (0.927‐1.775) | 0.166 | 0.133 | ||
Age at diagnosis (y) | ≤60 | >60 | 1.962 (1.674‐2.298) | 0.081 | <0.001 |
Grade | Grade I | Grade II | 1.125 (0.738‐1.714) | 0.215 | 0.583 |
Grade III | 2.077 (1.331‐3.241) | 0.227 | 0.001 | ||
Grade IV | 2.899 (1.685‐4.987) | 0.277 | <0.001 | ||
Unknown | 1.027 (0.584‐1.805) | 0.288 | 0.926 |